Passage Bio

@Passage_Bio

Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.

Philadelphia, PA
Vrijeme pridruživanja: lipanj 2019.

Tweetovi

Blokirali ste korisnika/cu @Passage_Bio

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Passage_Bio

  1. 20. sij

    Frontotemporal dementia, or FTD, typically presents in the 6th or 7th decade of life with progressive impairment of executive function, language and social interaction.

    Poništi
  2. proslijedio/la je Tweet
    7. pro 2019.

    The total number of Americans living with a is estimated at between 25-30 million. This estimate has been used by the rare disease community for decades to highlight that individual diseases may be rare, but the total number of people with a rare disease is large.

    Poništi
  3. 15. sij

    At Passage Bio, our mission is to discover and develop life-transforming therapies for patients with rare monogenic CNS diseases, while also building strong relationships with the communities we serve. Learn how you can support our mission at

    Poništi
  4. proslijedio/la je Tweet
    6. sij

    BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of the top up-and-coming life science companies in North America.

    Poništi
  5. 3. sij

    Entering this new year, we are committed to developing promising therapies that could change the future of rare diseases for patients and families. Here's to a productive 2020!

    Poništi
  6. 31. pro 2019.

    As we reflect on 2019, we at Passage Bio are proud of the work we've accomplished, and excited to expand our efforts in 2020. With several promising therapies in the pipeline, we're ready to leap into the new year with renewed focus. Here's to a productive and successful 2020!

    Poništi
  7. 20. pro 2019.

    This holiday season we wish that all families with children with rare diseases are able to have peace, togetherness, and hope for progress on new treatments.

    Poništi
  8. proslijedio/la je Tweet
    5. pro 2019.

    Traveling this holiday season? We've put together a list of our favorite podcasts to get you through any snow storm, traffic jam or flight delay.

    Poništi
  9. 11. pro 2019.

    We will be attending the Summit in Boston this year, sharing knowledge with experts in gene therapy for neurological disorders. We're looking forward to identifying improvement areas and opportunities to guide our research!

    Poništi
  10. 6. pro 2019.

    Did you know? GM1 gangliosidosis is an autosomal recessive genetic disorder. Many infantile GM1 patients experience rapid regression with mortality by approximately two years of age. Learn more about why we're developing a program to treat GM1:

    Poništi
  11. 27. stu 2019.

    On we are grateful for our wonderful team that every day dedicates themselves to developing life transforming genetic medicines for rare monogenic central nervous system diseases. Each and every one of you is instrumental to this fight, and we are lucky to have you!

    Poništi
  12. 22. stu 2019.
    Poništi
  13. 20. stu 2019.

    On Universal Children's Day, we are reminded of all the children around the world who are living with Krabbe and GM1. Their fight inspires us every day!

    Poništi
  14. proslijedio/la je Tweet

    In a video, of highlights the importance of infusing what matters most to families in every element of the development of new treatments for , & collaborating with urgency.

    Poništi
  15. 14. stu 2019.

    'Tis the season! Donate a new toy to a child in the hospital this through our Online Holiday for !

    Poništi
  16. 8. stu 2019.

    ! We are looking back at the incredible experience we had with 's Family meeting last month, and the wonderful families we were able to meet. They are why we do what we do

    Poništi
  17. proslijedio/la je Tweet

    Not enough people with take part in . If we want to make progress in care and treatments, we have to change that. can make a huge difference - tell your patients about research opportunities today! 👉

    Poništi
  18. proslijedio/la je Tweet
    18. ruj 2019.

    The NEXT report looks at how technology is improving our ability to diagnose and develop treatments. Catch our session surrounding the topic during Friday's closing session.

    Poništi
  19. 6. stu 2019.

    November is Month, and while FTD and Alzheimer's can seem similar, it is important to recognize their differences to avoid misdiagnosis. Check out this article from -

    Poništi
  20. 31. lis 2019.

    We had a blast at our Halloween Spooktacular celebration this morning. everyone!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·